Articles related to Endocrinology, Diabetes, Metabolism
AI and 10 Seconds of Voice can Screen for Diabetes, New Study Reveals
Unlocking a new era in diabetes detection, Klick Labs’ study showcases the transformative power of voice technology and AI. With 10 seconds of voice and basic health data, an accuracy of 89% for women and 86% for men is achieved, heralding a potential revolution in healthcare screening.
Endocrinology, Diabetes, Metabolism November 28th 2023
MKSAP Quiz: Follow-up of Hypoparathyroidism
Stay updated with the latest advancements in the management of hypoparathyroidism. Enhance your knowledge and improve patient outcomes by understanding the nuances of diagnosis and treatment.
Endocrinology, Diabetes, Metabolism November 15th 2023
Images in Clinical Medicine: Acquired Reactive Perforating Collagenosis
This case serves as a reminder that dermatological symptoms can be indicators of systemic conditions. The patient’s glycated hemoglobin value of 8.5% a year before presentation underscores the potential link between diabetes and skin conditions like acquired reactive perforating collagenosis.
Dermatology November 8th 2023
The Clinical Picture: Hyperpigmentation as a Clue to Addison Disease
A recent case study stresses the importance of considering Addison disease in patients presenting with long-standing hyperpigmentation. Notably, the patient’s potassium level was found to be 5.7 mmol/L (reference range 3.6–4.8) at admission.
Endocrinology, Diabetes, Metabolism November 2nd 2023
Jardiance Approved for Adults with Chronic Kidney Disease
The approval of empagliflozin opens up a new avenue in CKD treatment. With its proven efficacy in reducing the risk of disease progression by 28%, it offers a promising alternative for healthcare professionals dealing with this prevalent condition.
Endocrinology, Diabetes, Metabolism October 30th 2023
Despite Discounts, Insulin Prices Remain High
The study’s findings underscore the importance of addressing the high cost of insulin. Despite new products and discounts entering the market, one in four patients still report cost as a barrier to accessing their necessary insulin.
Clinical Pharmacology October 30th 2023